Bedoelde u
performed

Zoekresultaten - 56 results

Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study

for self-collection were clear, that collection was easy, and that they were confident about having performed the procedure correctly, for both urine and vaginal collection. However, a proportion of ...

Stakeholder Coalitions and Priorities Around the Policy Goals of a Nation-Wide Mental Health Care Reform

analysis on stakeholders’ policy priorities. A belief network analysis was performed to identify the central and peripheral policy goals within coalitions. Coalitions brought together stakeholders with ...

Tackling cervical cancer in Europe amidst the COVID-19 pandemic.

low in countries with the highest incidence and screening performance is heterogeneous among European countries. Cytological screening followed by treatment of screen-detected cervical lesions has ...

The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer

in the analysis and observed how these factors interplay to determine the working status. After having solved legal, ethical and technical issues for the coupling, we will perform survival analysis ...

Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia

neoplasia (CIN) and cancer; treating cervical abnormalities and cancer; and vaccinating women treated for CIN2 /3 to prevent recurrence. Evaluations will be performed using a simulation model, Policy1-Cervix ...

Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.

whole female population were obtained from the two cancer registries. During 2008-2011, 565 153 smears were performed in 498 913 women aged 25-64 years, representing an average of 1.13 smears/woman and ...

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.

HPV assays with genotyping capability. In VALGENT-3, the clinical and analytical performance of Anyplex II HPV HR detection (Anyplex) was compared to that of the Hybrid Capture 2 HPV DNA test (hc2) and ...

Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.

Neoplasms Abstract: In this diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping II (INNO-LiPA) within the VALGENT-3 framework. ...

The use of the permanent sample (eps) to study the returnto- work after cancer. Challenges and opportunities for research

We suggest some modifications of the EPS that might offer scientists better opportunities to improve the performance and reliability of such cohort studies. Health Topics:  Cancer Quality of healthcare ...

Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel.

performance of various HPV tests relative to the validated and accepted comparator test in a formalized and uniform manner. The aim of this study was to evaluate the clinical performance of the HPV-Risk assay ...

QR code

QR code for this page URL